Octavian Therapeutics
PrivateLast Round
Early Funding
Mar 1, 2025
Est. Valuation
$72.57M
Total Funding Raised
$22.36M
Company Overview
Octavian Therapeutics is a biopharmaceutical company focused on developing innovative prescription medicines targeting the endocannabinoid system to treat chronic neuropathic pain and other debilitating conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Octavian Therapeutics Comparables
Compare Octavian Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MIRA Pharmaceuticals, Inc. | 78% | |
| BRC Therapeutics | 78% | |
| Centrexion Therapeutics | 78% |
Octavian Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 1, 2025 | ||||
| IPO | May 21, 2021 | ||||
| Series A | Jun 28, 2018 | ||||
| Seed | Mar 17, 2017 |
Octavian Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Casa Verde Capital | Series A |
| Kingsley Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2021
$23.25M raised in IPO round.
- Jun 28, 2018
$10M round led by Casa Verde Capital.
Octavian Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Octavian Therapeutics's valuation, stock price, and market status.
Is Octavian Therapeutics a public or private company?
Octavian Therapeutics is a private company.
What is the current stock price of Octavian Therapeutics?
Octavian Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Octavian Therapeutics worth (valuation)?
Octavian Therapeutics's valuation is estimated at $72.6M based on funding round data.
Can I buy Octavian Therapeutics stock?
Octavian Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Octavian Therapeutics's last funding round?
Octavian Therapeutics's most recent funding round was Early Funding on May 21, 2021.
Who are the main investors in Octavian Therapeutics?
Key investors in Octavian Therapeutics include Kingsley Capital Partners.
Will Octavian Therapeutics IPO soon?
No public IPO plans have been announced for Octavian Therapeutics.
How can I track Octavian Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Octavian Therapeutics's secondary market activity and sign up for updates.